Alexion Pharmaceuticals

Alexion’s ravulizumab granted FDA orphan designation

Alexion Pharmaceuticals’ ravulizumab for the prevention of delayed graft function after renal transplantation was granted FDA orphan ...

pharmaphorum2d

Alexion trials rare disease drug Ultomiris in severe COVID-19 cases

Pharma is pretty much throwing everything it has at COVID-19 and US rare disease firm Alexion has joined the fray, testing its Ultomiris in a subset of severely ill patients.

pharmaphorum1d

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

Alexion is a somewhat unique pharma company in that it focuses almost entirely on rare diseases – and although this is an immensely challenging area to operate in, the company’s senior vice ...

Hosted on MSN11mon

FDA grants approval for Alexion’s NMOSD treatment

AstraZeneca recently entered an agreement to acquire Fusion Pharmaceuticals for up to $2.4bn in a strategic move to expand its portfolio. "FDA grants approval for Alexion’s NMOSD treatment" was ...

Fortune2y

Alexion Pharmaceuticals

Nature4y

At Alexion, people living with rare diseases are our inspiration and our Guiding Star

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing medicines.

Hosted on MSN3mon

Pharmaceutical giant addresses critical health issue by rethinking its delivery trucks: 'Another milestone'

To address this impact, pharmaceutical giant Alexion is partnering with global transportation company DHL to incorporate alternative fuels into its fleet. An article from Irish Tech News discussed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results